Jacinda Chan
Medical · Sacramento, CANPI 1588265854
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.4%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Galderma Laboratories, L.p. at 35.4% of the total. 2025 is the largest year on record at $19,358, more than ten times the $1,514 reported in 2022. Among medical clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 548 payments — averaging $56.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$11K
- Incyte Corporation$4K
- AbbVie$3K
- Sun Pharmaceutical Industries Inc.$2K
- UCB, Inc.$2K
- E.r. Squibb & Sons, L.L.C.$2K
- plus $8K from 24 others
What the payments were for
- Consulting fees$5,18217%
- Speaking & faculty fees$9,37531%
- Travel & lodging$2751%
- Food & beverage$15,17549%
- Education$6822%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 32 | $10,865 |
| Incyte Corporation | 93 | $3,576 |
| AbbVie | 61 | $2,712 |
| Sun Pharmaceutical Industries Inc. | 39 | $2,085 |
| UCB, Inc. | 27 | $1,944 |
| E.r. Squibb & Sons, L.L.C. | 35 | $1,694 |
| Arcutis Biotherapeutics, Inc. | 47 | $1,445 |
| Lilly USA, LLC | 45 | $1,121 |
| Sanofi | 17 | $819 |
| Regeneron Healthcare Solutions, Inc. | 26 | $738 |
| Johnson & Johnson | 15 | $538 |
| Dermavant Sciences, Inc. | 12 | $518 |
| Pfizer | 28 | $501 |
| Novartis | 25 | $500 |
| LEO Pharma Inc. | 9 | $293 |
| Verrica Pharmaceuticals Inc. | 6 | $220 |
| Biocon Biologics Inc | 1 | $176 |
| Boehringer Ingelheim | 3 | $167 |
| Janssen Scientific Affairs, LLC | 2 | $144 |
| Botanix SB Inc | 7 | $128 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $85 |
| Amgen | 4 | $85 |
| Genentech USA, Inc. | 1 | $73 |
| EPI Health, LLC | 1 | $38 |
| GSK | 1 | $35 |
| Kyowa Kirin, Inc. | 2 | $31 |
| Organon | 2 | $25 |
| Blueprint Medicines Corporation | 1 | $22 |
| LNHC, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$30,689 in reported general payments places this provider in the 95th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 54 | $205,079 |
| OpzeluraRuxolitinib Phosphate | 43 | $82,131 |
| Taltz AutoinjectorIxekizumab | 11 | $71,972 |
| SotyktuDeucravacitinib | 11 | $67,371 |
| JubliaEfinaconazole | 23 | $33,437 |
| ZoryveRoflumilast | 21 | $16,981 |
| Tacrolimus | 55 | $12,927 |
| Betamethasone Dipropionate | 155 | $9,248 |
| Clobetasol Propionate | 93 | $4,861 |
| Ketoconazole | 257 | $4,364 |
| Fluocinonide | 96 | $2,956 |
| Triamcinolone Acetonide | 172 | $1,877 |
| Clindamycin Phosphate | 43 | $1,640 |
| Ciclopirox | 28 | $1,271 |
| Doxycycline Monohydrate | 29 | $852 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Incyte CorporationOpzelura | $3,576 | $82,13143 claims |
| E.r. Squibb & Sons, L.L.C.Sotyktu | $1,694 | $67,37111 claims |
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $85 | $33,43723 claims |
| Arcutis Biotherapeutics, Inc.Zoryve | $1,445 | $16,98121 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,087 medical providers in California.
Other medical in Sacramento
- Kathryn CunninghamSacramento$91K
- Joshua OppermanSacramento$26K
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- David DoriguzziLancaster$166K
- Deirdre MoxleyFullerton$149K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.